Definium Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2020 | $5.7M | $81.5M | $80.1M |
| Dec 2021 | $12.3M | $164.0M | $133.5M |
| Mar 2022 | $12.4M | $149.2M | $120.5M |
| Jun 2022 | $9.8M | $134.3M | $105.7M |
| Sep 2022 | $27.3M | $180.9M | $154.5M |
| Dec 2022 | $19.1M | $170.0M | $142.1M |
| Mar 2023 | $25.2M | $155.5M | $129.4M |
| Jun 2023 | $36.1M | $142.1M | $116.9M |
| Sep 2023 | $45.6M | $141.6M | $117.7M |
| Dec 2023 | $46.4M | $124.5M | $99.7M |
| Mar 2024 | $79.5M | $275.5M | $252.3M |
| Jun 2024 | $66.1M | $268.1M | $243.1M |
| Sep 2024 | $57.6M | $319.8M | $295.3M |
| Dec 2024 | $60.7M | $302.2M | $273.7M |
| Mar 2025 | $52.5M | $275.3M | $82.9M |
| Jun 2025 | $79.7M | $265.1M | $33.4M |
| Sep 2025 | $106.3M | $236.9M | $20.0M |
| Dec 2025 | $107.8M | $440.1M | $257.8M |
| Mar 2026 | $122.4M | $401.3M | $262.5M |
| Jun 2026 | $194.2M | $1.11B | $655.3M |